Canada: Canadian Cannabis Companies Gaining Traction In Capital Markets South Of The Border: First Cannabis Listing On NYSE Commenced Today

Last Updated: May 25 2018
Article by Henry A. Harris and Stephen Franchetto (Articling Student)

Most Read Contributor in Canada, October 2018

With the Cannabis Act (Bill C-45) set to be voted on by the Senate of Canada in two weeks (June 7, 2018) and legalization of marijuana expected in the coming months, Canada's largest cannabis company today became the first marijuana producer to be approved for listing on the New York Stock Exchange (NYSE). The listing on the NYSE of Canopy Growth Corporation, with a market capitalization of C$7.74 billion, represents another milestone as major Canadian investment dealers and U.S. stock exchanges are demonstrating a willingness to wade into the cannabis industry for the first time. In January/February, the Bank of Montreal (BMO) co-led Canopy's C$200 million bought deal public offering, the first time a major Canadian bank-owned dealer had accepted an engagement from an issuer with marijuana-related activities. Further transactions and listings on U.S. stock exchanges, including Cronos Group Inc.'s listing on NASDAQ earlier this year, suggest that issuers with marijuana-related activities are gaining broader acceptance as the cannabis industry matures.

Gowling WLG Focus

Transactions involving issuers with marijuana-related activities had, until recently, been avoided by Canada's major bank-owned investment dealers due to reputational perception, as well as the grey area surrounding the legality of cannabis in the U.S. where most Canadian banks have a significant presence. This appears to be changing with BMO's recent roles in 2018 financings and acquisitions as discussed below. While Canada's other "Big Five" banks (RBC, Scotia, TD, CIBC and National Bank) have not yet been active in cannabis transactions, the success of these financings and acquisitions, along with the anticipated legalization of marijuana in Canada in the coming months, may prompt a reassessment of their positions in the cannabis industry which has been dominated by independent investment dealers such as Canaccord Genuity Corp. and GMP Capital Inc.

Canopy's listing on the NYSE today also represents a potential new pathway for Canadian marijuana companies to access capital, particularly from U.S. institutional investors, and to establish a global market presence. Opportunities to access new sources of capital may be highly valuable to issuers given the anticipated industry consolidation.

Despite the potential opportunities in the cannabis industry, the regulatory landscapes in Canada and the U.S. are complex and have changed frequently in the past year.  Although legalization is expected to occur in Canada in the second half of 2018, new regulations have not been released and it is unclear how Canadian securities regulators and stock exchanges may respond to the passage of final legislation.  

Cannabis Industry Transactions and Stock Exchange Listings

BMO's engagement on a number of transactions involving large-cap cannabis companies in the past five months signals growing market acceptance of the cannabis industry. BMO co-led Canopy's C$200 million bought deal public offering in January/February1, the first such foray into the cannabis industry by a major bank-owned dealer. While other major Canadian banks have not yet participated in the market, BMO appears to have recognized the investment potential in the industry, subsequently co-leading Cronos' C$100 million bought offering in March/April2 and advising on two potential acquisitions by Canadian issuers with marijuana-related activities. BMO is acting as financial adviser to Hiku Brands Company Ltd. in connection with its proposed C$288 million acquisition of WeedMD Inc.3 Most recently,  Aurora Cannabis Inc. announced its proposed C$3.2 billion acquisition of MedReleaf Corp., a transaction which if completed, would establish Aurora Cannabis as the largest issuer with marijuana-related activities in Canada4.  BMO acted as advisor to Aurora Cannabis on the acquisition. BMO's entrance to the cannabis industry marks a shift in Canadian capital markets, and further opportunity for issuers with marijuana-related activities if Canada's other major bank-owned dealers begin to embrace the investment potential in the cannabis market.

Canopy's listing on the NYSE and Cronos' earlier listing on the NASDAQ5 represent the first listings by issuers with marijuana-related activities on the respective U.S. stock exchanges. Unlike issuers based in Canada, U.S.-based issuers are currently unable to list on U.S. exchanges, as discussed further below. Canopy and Cronos' successful cross-listings in the U.S. mark a significant industry development, providing Canadian issuers with easier access to capital from U.S. investors6 and promoting global development. Canopy has previously succeeded in attracting U.S. capital. In November 2017, the company closed a C$245 million equity investment by NYSE-listed Constellation Brands Inc., in exchange for common shares representing a 9.9% stake in Canopy and warrants permitting Constellation to double its interest7. The investment also appears to have strategic value as the parties are expected to collaborate on a line of cannabis-infused beverages.

Canadian and U.S. Regulatory Developments

The Canadian federal Cannabis Act, Bill C-45, is currently being debated by committees of the Senate of Canada8 and is scheduled to come to the floor for a vote on or before June 7, 2018. The Government of Canada has maintained its position that marijuana will be legalized pursuant to the Cannabis Act in the second half of 2018, notwithstanding calls to delay its implementation.9

Despite the existence of permissive regulatory regimes in many individual U.S. states, marijuana remains illegal under U.S. federal law as a Schedule I drug under the U.S. Controlled Substances Act. Accordingly, U.S. stock exchanges have prevented companies with U.S. marijuana-related operations from listing due to such illegality10. In contrast, the Access to Cannabis for Medical Purposes Regulations (ACMPR), already provide a uniform set of regulations related to the production, sale or distribution of medical cannabis in Canada. The regulated nature of the cannabis industry in Canada, pursuant to the ACMPR, creates the opportunity for Canadian companies to list on stock exchanges in both Canada and the U.S.

In February 2018, Canadian securities regulators provided updated guidance to Canadian issuers with U.S. marijuana-related activities in response to the January rescission of the 2013 Cole Memorandum. The Cole Memorandum had deferred prosecution of marijuana-related offences where states had enacted "strong and effective" regulatory programs. Canadian securities regulators continue to support a disclosure-based approach to regulating Canadian issuers with U.S. marijuana-related activities, but have enhanced the disclosure required in offering documents, including prospectuses, listing statements and marketing materials, as well as continuous disclosure documents such as the annual information form and management's discussion and analysis.

The Toronto Stock Exchange (TSX) and TSX Venture Exchange (TSXV) have required issuers with U.S. marijuana-related activities to sell assets based in the U.S. in order to comply with minimum listing requirements. In contrast, the Canadian Securities Exchange (CSE) has not required listed companies to dispose of U.S.-based assets. In adopting a less restrictive regulatory approach than the TSX and TSXV, the CSE has become an attractive option for U.S. companies seeking access to the Canadian capital markets. MedMen Enterprises (MM Enterprises, USA, LLC), a $1 billion Los Angeles-based company operating dispensaries in a range of U.S. cities recently announced plans to complete a reverse takeover to list on the CSE, in order to gain access to Canadian capital markets11.

Next Steps

With legalization of marijuana on the horizon in Canada, major Canadian financial institutions are likely to reassess the attendant risks of underwriting or advising on transactions involving Canadian issuers with marijuana-related activities, potentially creating new opportunities for partnerships. Issuers of varying scale may benefit from new pathways to access capital, both in Canada and abroad, including through cross-listing on U.S. exchanges.

Gowling WLG is monitoring financing trends and regulatory developments in Canada and the United States and is well-positioned to assist TSX, TSXV and CSE-listed issuers with meeting their ongoing disclosure obligations and potential cross-listing opportunities.  


1 Canopy Growth Corp., News Release, "Canopy Growth Corporation Completes Previously Announced Bought Deal Financing for $200 Million" (7 February 2018), online: (

2 Cronos Group Inc., News Release, "Cronos Group Announces Closing of Previously Announced $100 Million Bought Deal" (6 April 2018), online: (

3 Doug Alexander, "Bank of Montreal muscles into marijuana M&A by advising Aurora in biggest deal yet", The National Post (14 May 2018), online: (

4 Aurora Cannabis Inc., News Release, "Aurora Cannabis to Acquire MedReleaf" (14 May 2018), online:  (

5 Jennifer Kaplan and Erik Schatzker, "Nasdaq to get first pot listing as Canada's Cronos Group joins exchange", The Globe and Mail (26 February 2018), online: (

6 Kristine Owram, "Canopy Growth applies to become first pot producer listed on the NYSE", The National Post (14 May 2018), online: (

7 Canopy Growth Corp., News Release, "Canopy Growth and Constellation finalize previously announced strategic transaction" (2 November 2017), online: (

8 Senate of Canada, The Cannabis Act in the Senate (19 April 2018), online: (

9 Elise von Scheel, "Senate could sit into summer to pass marijuana bills", CBC News (11 May 2018), online: (

10 Chloe Aiello, "Canadian marijuana company's Nasdaq listing bodes well for the industry, but US companies still face barriers", CNBC (6 March 2018), online: (

11 Ladera Ventures Corp., News Release, "Ladera Ventures Announces Proposed Reverse Takeover By MedMen Enterprises" (30 April 2018), online: (

Read the original article on

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Topics
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions